154 related articles for article (PubMed ID: 9088910)
1. Genetic characterization of senescence-accelerated mouse (SAM).
Higuchi K
Exp Gerontol; 1997; 32(1-2):129-38. PubMed ID: 9088910
[TBL] [Abstract][Full Text] [Related]
2. Senescence-accelerated mouse (SAM): a biogerontological resource in aging research.
Takeda T
Neurobiol Aging; 1999; 20(2):105-10. PubMed ID: 10537019
[TBL] [Abstract][Full Text] [Related]
3. Senescence-accelerated mouse (SAM): a novel murine model of senescence.
Takeda T; Hosokawa M; Higuchi K
Exp Gerontol; 1997; 32(1-2):105-9. PubMed ID: 9088907
[TBL] [Abstract][Full Text] [Related]
4. Genetic typing of the senescence-accelerated mouse (SAM) strains with microsatellite markers.
Xia C; Higuchi K; Shimizu M; Matsushita T; Kogishi K; Wang J; Chiba T; Festing MF; Hosokawa M
Mamm Genome; 1999 Mar; 10(3):235-8. PubMed ID: 10051317
[TBL] [Abstract][Full Text] [Related]
5. Genetic analysis of lifespan in hybrid progeny derived from the SAMP1 mouse strain with accelerated senescence.
Guo Z; Toichi E; Hosono M; Hosokawa T; Hosokawa M; Higuchi K; Mori M
Mech Ageing Dev; 2000 Sep; 118(1-2):35-44. PubMed ID: 10989123
[TBL] [Abstract][Full Text] [Related]
6. Exome sequencing of senescence-accelerated mice (SAM) reveals deleterious mutations in degenerative disease-causing genes.
Tanisawa K; Mikami E; Fuku N; Honda Y; Honda S; Ohsawa I; Ito M; Endo S; Ihara K; Ohno K; Kishimoto Y; Ishigami A; Maruyama N; Sawabe M; Iseki H; Okazaki Y; Hasegawa-Ishii S; Takei S; Shimada A; Hosokawa M; Mori M; Higuchi K; Takeda T; Higuchi M; Tanaka M
BMC Genomics; 2013 Apr; 14():248. PubMed ID: 23586671
[TBL] [Abstract][Full Text] [Related]
7. A higher oxidative status accelerates senescence and aggravates age-dependent disorders in SAMP strains of mice.
Hosokawa M
Mech Ageing Dev; 2002 Nov; 123(12):1553-61. PubMed ID: 12470893
[TBL] [Abstract][Full Text] [Related]
8. [Senescence-accelerated mouse (SAM): with special reference to age-associated pathologies and their modulation].
Takeda T
Nihon Eiseigaku Zasshi; 1996 Jul; 51(2):569-78. PubMed ID: 8783874
[TBL] [Abstract][Full Text] [Related]
9. Accelerated senile amyloidosis induced by amyloidogenic Apoa-II gene shortens the life span of mice but does not accelerate the rate of senescence.
Higuchi K; Wang J; Kitagawa K; Matsushita T; Kogishi K; Naiki H; Kitado H; Hosokawa M
J Gerontol A Biol Sci Med Sci; 1996 Jul; 51(4):B295-302. PubMed ID: 8680995
[TBL] [Abstract][Full Text] [Related]
10. Murine leukemia virus in organs of senescence-prone and -resistant mouse strains.
Carp RI; Meeker HC; Chung R; Kozak CA; Hosokawa M; Fujisawa H
Mech Ageing Dev; 2002 Mar; 123(6):575-84. PubMed ID: 11850021
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetic characterization of the senescence-accelerated mouse (SAM) strains.
Kitado H; Higuchi K; Takeda T
J Gerontol; 1994 Nov; 49(6):B247-54. PubMed ID: 7963272
[TBL] [Abstract][Full Text] [Related]
12. Senescence-accelerated mouse (SAM) with special references to neurodegeneration models, SAMP8 and SAMP10 mice.
Takeda T
Neurochem Res; 2009 Apr; 34(4):639-59. PubMed ID: 19199030
[TBL] [Abstract][Full Text] [Related]
13. Differences in saccharin preference and genetic alterations of the Tas1r3 gene among senescence-accelerated mouse strains and their parental AKR/J strain.
Niimi K; Takahashi E
Physiol Behav; 2014 May; 130():108-12. PubMed ID: 24726396
[TBL] [Abstract][Full Text] [Related]
14. [Anti-aging studies on the senescence accelerated mouse (SAM) strains].
Takahashi R
Yakugaku Zasshi; 2010 Jan; 130(1):11-8. PubMed ID: 20046059
[TBL] [Abstract][Full Text] [Related]
15. Age-related expression of sigma1 receptors and antidepressant efficacy of a selective agonist in the senescence-accelerated (SAM) mouse.
Phan VL; Miyamoto Y; Nabeshima T; Maurice T
J Neurosci Res; 2005 Feb; 79(4):561-72. PubMed ID: 15635598
[TBL] [Abstract][Full Text] [Related]
16. Wild type ApoA-II gene does not rescue senescence-accelerated mouse (SAMP1) from short life span and accelerated mortality.
Wang J; Matsushita T; Kogishi K; Xia C; Ohta A; Chiba T; Nakamura A; Kondo H; Mori M; Hosokawa M; Higuchi K
J Gerontol A Biol Sci Med Sci; 2000 Sep; 55(9):B432-9. PubMed ID: 10995040
[TBL] [Abstract][Full Text] [Related]
17. Senescence-accelerated mouse (SAM) as an animal model of senile dementia: pharmacological, neurochemical and molecular biological approach.
Okuma Y; Nomura Y
Jpn J Pharmacol; 1998 Dec; 78(4):399-404. PubMed ID: 9920195
[TBL] [Abstract][Full Text] [Related]
18. Immune abnormality in relation to nonimmune diseases in SAM mice.
Hosono M; Hanada K; Toichi E; Naiki H; Higuchi K; Hosokawa T
Exp Gerontol; 1997; 32(1-2):181-95. PubMed ID: 9088915
[TBL] [Abstract][Full Text] [Related]
19. The senescence-accelerated mouse (SAM): a higher oxidative stress and age-dependent degenerative diseases model.
Chiba Y; Shimada A; Kumagai N; Yoshikawa K; Ishii S; Furukawa A; Takei S; Sakura M; Kawamura N; Hosokawa M
Neurochem Res; 2009 Apr; 34(4):679-87. PubMed ID: 18688709
[TBL] [Abstract][Full Text] [Related]
20. [Effect of epitalon and melatonin on life span and spontaneous carcinogenesis in senescence accelerated mice (SAM)].
Anisimov VN; Popovich IG; Zabezhinskiĭ MA; Rozenfel'd SV; Khavinson VKh; Semenchenko AV; Iashin AI
Vopr Onkol; 2005; 51(1):93-8. PubMed ID: 15909815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]